Hepatocellular carcinoma: epidemiology, risk factors, and screening.
about
Interferon lambda: a new sword in cancer immunotherapySurgical resection versus liver transplant for patients with hepatocellular carcinomaLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaSurgical resection for hepatocellular carcinomaCD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infectionIncreased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and CirrhosisHepatocellular carcinoma: Epidemiology, risk factors and pathogenesisMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsIn vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analogThe histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibitionCombined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinomaGender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionAltered protein expression at early-stage rat hepatic neoplasia.Thermal ablation of hepatocellular carcinoma.Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.THE HERBAL MIXTURE XIAO-CHAI-HU TANG (XCHT) INDUCES APOPTOSIS OF HUMAN HEPATOCELLULAR CARCINOMA HUH7 CELLS IN VITRO AND IN VIVO.Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosisIn vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancerRetrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.Roles of CXCL5 on migration and invasion of liver cancer cellsSynergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.Progenitor-derived hepatocellular carcinoma model in the rat.Is chronic hepatitis C virus infection a risk factor for breast cancer?Accelerated hepatocellular carcinoma development in CUL4B transgenic miceSTC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathwaysComparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinomaPrognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.Hypoglycemia, an atypical early sign of hepatocellular carcinoma.Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeHepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Risk factors for residual tumor after resection of hepatocellular carcinoma.
P2860
Q21296797-A9E4BD0C-961F-49AF-BA31-AEE6A04088F4Q24201773-DFB64FB7-ABB0-4FA8-8342-3B2B2C97DB58Q24234212-29E1B23C-3150-4299-ACBE-5A5E79B68F79Q24236020-4CA22FA5-CCD5-404D-A604-9EF7AAF9B648Q24243619-69640BDF-1C23-4BE6-ADD6-92EA2B230035Q24645322-6555BDFC-C6C9-4004-8A51-AB3BA6179D47Q27485310-BF7CACFA-9233-4427-98A0-AEAE2498FCF1Q27489394-6EF2D4AD-1E0E-48D4-939E-0DA68DF1EDBCQ28383646-73ACDF4A-502E-4D10-80CB-B383298775FEQ28484672-FE7A38B7-72A7-4EA9-8E61-2054F279E02AQ28542639-60AE178E-4388-4F89-AB00-34BA0E685EE2Q28728155-36AB2B16-FB15-447F-AD96-B269AB428FF2Q29614596-CC367570-893B-4633-94C6-F498AB94C973Q33271648-71A419CD-D857-4308-B5BA-94DC1077A436Q33323261-C6046D1A-443A-4A7D-81AA-40EC273EEE73Q33516543-B8A93D26-377A-4946-8C3E-BB43F96EAAC3Q33561833-E0229634-F9E8-4CF1-9AF8-13264D07507FQ33624057-4D49AC97-02D4-477B-AE1E-578F9D1BDA28Q33682219-468252C6-2F36-4062-A599-42BBC00342ABQ33728605-86C5039B-B87F-4CD6-8568-B549154AA41DQ33833557-B14C5CC0-229C-48BB-9FAD-B244CC42FF09Q33849055-C22B968D-D476-4F34-AF40-D344ADB67AA4Q33858898-B5F88BCA-E780-4FC8-BD17-0974C9F2AC9AQ33897910-DACEB79F-6816-495B-8A4B-0B8CC716E433Q33910326-B0945E37-2BDA-4DCA-BF24-392CAD4DEF20Q33962495-CC2F4C86-F391-4D14-876C-46FAB3AACFFCQ33966603-BA7E9D19-8474-4471-9B2E-B3C9BCC97B1BQ34037698-16DCC4FF-5DEC-4137-8B0F-D500DDF3D914Q34041411-2D10621C-A53F-4F98-95C3-FB3DC09BCA42Q34043935-CCB6BB53-EB9C-4222-83DF-98026E5F4BC7Q34049143-F93663A8-C489-49FC-9532-72BFEEB3E8B2Q34098540-E6414DF4-9D0C-42F5-988C-EF04377A2498Q34309479-DE28AFE3-DAD7-4A7C-8A3C-E6DC13F00918Q34362542-FF68C244-F443-4A96-B122-931D17E9B222Q34364217-25BB383C-D1F9-418A-8A9E-5A5FD5E62910Q34446810-19B3A36A-651B-4007-A941-F19EE63F5783Q34617432-4045A837-AC9B-4ACF-8246-94F3E85AC404Q34619635-2E39B4C8-B248-47EB-9C31-AEF7B104D824Q34765478-1B8857BB-213F-490F-92B0-428410E85789Q34831310-1DDBFBB6-A303-49FF-9255-8A467648C4E1
P2860
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@ast
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@en
type
label
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@ast
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@en
prefLabel
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@ast
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@en
P356
P1476
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
@en
P2093
Morris Sherman
P304
P356
10.1055/S-2005-871194
P577
2005-01-01T00:00:00Z